NANA – Registry-based non-randomized studies for assessing the benefits and harms of drugs

Department of Medical Statistics

The research team in the NANA project is investigating whether it is currently possible and sensible to use the registry data available in Germany for assessing the benefits and harms of new drugs. 
For this purpose, the team is carrying out ten to twelve register-based non-randomized studies. The results of these analyses will be compared with the existing results on the same clinical question from randomised controlled trials.

The project aims to provide insights into the circumstances under which an analysis based on routinely collected data can provide reliable results on the benefits and harms of drugs and which aspects need to be carefully considered when such analyses are implemented.

The project is funded by the “Federal Joint Committee”. Find here the project description of the “Innovationsausschuss”.

Contact